Daniel Morgenstern: Clinical Trials

2 trials sponsored by Daniel Morgenstern, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting. 1 Early Phase 1, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Early Phase 11Recruiting 1
Not applicable1Recruiting 1

Follow Daniel Morgenstern: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Pilot Study Investigating Upfront Adaptive Immunotherapy Approach in Children, Adolescent and Young Adult (CAYA) Patients With Replication-Repair Deficient (RRD) High-Grade Gliomas (HGG)
Nivolumab, Radiation - High Grade Glioma, Replication Repair Deficient
Not applicableRecruitingDaniel Morgenstern202024-12-062025-08-29
Pilot Study of Vinblastine and Tovorafenib in Pediatric Patients With Recurrent/Progressive RAF Altered Low Grade Gliomas
Tovorafenib, Vinblastine - Low-grade Glioma
Early Phase 1RecruitingDaniel Morgenstern572024-03-212025-05-15

Conditions studied

Glioma (1)

Interventions

Nivolumab (1)  ·  Radiation (1)  ·  Vinblastine (1)  ·  tovorafenib (1)

Countries

Canada (2)